IRIS
NAVARINI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 6.154
NA - Nord America 2.465
EU - Europa 1.278
SA - Sud America 398
AF - Africa 81
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.399
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 4.249
US - Stati Uniti d'America 2.331
CN - Cina 876
IT - Italia 564
HK - Hong Kong 430
BR - Brasile 298
VN - Vietnam 189
GB - Regno Unito 174
BD - Bangladesh 149
FR - Francia 143
DE - Germania 99
IN - India 77
NL - Olanda 74
CA - Canada 67
MX - Messico 49
FI - Finlandia 37
AR - Argentina 32
ID - Indonesia 27
TR - Turchia 26
ZA - Sudafrica 26
ES - Italia 25
JP - Giappone 24
AT - Austria 23
EC - Ecuador 21
AU - Australia 19
UA - Ucraina 19
RU - Federazione Russa 18
PL - Polonia 17
CO - Colombia 16
EG - Egitto 13
PK - Pakistan 13
CZ - Repubblica Ceca 11
DK - Danimarca 11
LT - Lituania 11
IQ - Iraq 10
PE - Perù 10
SA - Arabia Saudita 9
TN - Tunisia 9
CL - Cile 8
PH - Filippine 8
IR - Iran 7
LB - Libano 7
SE - Svezia 7
UZ - Uzbekistan 7
BG - Bulgaria 6
IE - Irlanda 6
LY - Libia 6
MA - Marocco 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
JO - Giordania 5
MD - Moldavia 5
MY - Malesia 5
RO - Romania 5
BE - Belgio 4
DZ - Algeria 4
GT - Guatemala 4
IL - Israele 4
JM - Giamaica 4
OM - Oman 4
EE - Estonia 3
HN - Honduras 3
KE - Kenya 3
KZ - Kazakistan 3
RS - Serbia 3
TH - Thailandia 3
TL - Timor Orientale 3
VE - Venezuela 3
AZ - Azerbaigian 2
BH - Bahrain 2
BO - Bolivia 2
CR - Costa Rica 2
ET - Etiopia 2
GH - Ghana 2
HR - Croazia 2
LK - Sri Lanka 2
LV - Lettonia 2
NC - Nuova Caledonia 2
TW - Taiwan 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CV - Capo Verde 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
HT - Haiti 1
IS - Islanda 1
KH - Cambogia 1
KR - Corea 1
KW - Kuwait 1
LC - Santa Lucia 1
MG - Madagascar 1
MK - Macedonia 1
MM - Myanmar 1
Totale 10.386
Salva come PNG Salva come JPEG
Città #
San Jose 764
Singapore 611
Ashburn 454
Hong Kong 423
Rome 334
Dallas 267
Hefei 258
Beijing 235
Boardman 136
London 121
Lauterbourg 115
Shanghai 83
Council Bluffs 81
Ho Chi Minh City 76
Amsterdam 56
Munich 50
Santa Clara 45
New York 44
Los Angeles 42
Hanoi 36
Mexico City 28
Turku 23
São Paulo 22
Toronto 22
Milan 20
Naples 18
Pune 18
Ankara 17
Brooklyn 17
Tokyo 17
Washington 17
Bari 16
San Francisco 16
Atlanta 15
Warsaw 15
Frankfurt am Main 14
Haiphong 14
Helsinki 13
Chennai 12
Las Vegas 12
Hangzhou 11
Chicago 10
Johannesburg 10
Montreal 10
Nuremberg 10
Rio de Janeiro 10
Boston 9
Buffalo 9
Changsha 9
Jinan 9
Seattle 9
Vienna 9
Guangzhou 8
Jaguariúna 8
Orem 8
Qingdao 8
West Jordan 8
Brasília 7
Charlotte 7
Leicester 7
Turin 7
Baghdad 6
Guayaquil 6
Melbourne 6
Paris 6
Quito 6
Tripoli 6
Cape Town 5
Champlin 5
Da Nang 5
Dammam 5
Dublin 5
Hải Dương 5
Manaus 5
Miami 5
Pisa 5
Prague 5
Shijiazhuang 5
Tashkent 5
Amman 4
Beirut 4
Belo Horizonte 4
Biên Hòa 4
Brno 4
Bắc Giang 4
Cairo 4
Chaozhou 4
Chengdu 4
Cotia 4
Denver 4
Guarulhos 4
Guatemala City 4
Hyderabad 4
Kongens Lyngby 4
Lahore 4
Manchester 4
New Delhi 4
Noicattaro 4
Philadelphia 4
Porto Alegre 4
Totale 4.940
Salva come PNG Salva come JPEG
Nome #
Cardiovascular safety of anti-TNF-alpha therapies: Facts and unsettled issues. 223
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 220
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 220
Hepatic PPARs: their role in liver physiology, fibrosis and treatment 217
Relationship between leptin and regulatory T cells in systemic lupus erythematosus: preliminary results 208
New onset of psoriasis induced by secukinumab in a patient with ankylosing spondylitis: a case report 206
Cardiometabolic multimorbidity may identify a more severe subset of rheumatoid arthritis, results from a “real-life” study 204
Cytokine profile, ferritin, and multi-visceral involvement characterise macrophage activation syndrome during adult-onset Still's disease 195
Clinical characteristics of obese patients with adult-onset Still's disease. Data from a large multicentre cohort 192
Leptin in immuno-rheumatological diseases 190
Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 175
Clinical correlates of a subset of anti-fibroblast antibodies in systemic sclerosis 167
2-Arachidonoylglycerol Reduces the Production of Interferon-Gamma in T Lymphocytes from Patients with Systemic Lupus Erythematosus 165
Adult-onset Still's disease with elderly onset: results from a multicentre study 164
Bosentan effect on echocardiographic systolic pulmonary arterial pressure in systemic sclerosis-related pulmonary hypertension: a systematic review and metanalysis 164
Personal attitudes and denialist views about the COVID-19 pandemic in Italy: a national survey 144
A longitudinal study on caring behaviors of Italian nursing students 143
Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies 139
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 135
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study 122
The clinical assessment of lung involvement in patients with Still’s disease, results from the multicentre international AIDA Network Still’s Disease Registry 120
Angiogenic and angiostatic factors in renal scleroderma-associated vasculopathy 119
Association Between Minor Salivary Gland Biopsy During Sjӧgren's Syndrome and Serologic Biomarkers: A Systematic Review and Meta-Analysis 118
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 116
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 116
Clinical features of patients with systemic lupus erythematosus according to health-related quality of life, entity of pain, fatigue and depression: a cluster analysis 114
Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 114
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 113
Beauty is not perfection: what Leonardo’s Lady with an Ermine can suggest to aesthetic surgery 112
Endocannabinoid system in systemic lupus erythematosus: First evidence for a deranged 2-arachidonoylglycerol metabolism 108
Demographic and clinical differences between ankylosing spondylitis and non-radiographic axial spondyloarthritis: results from a multicentre retrospective study in the Lazio region of Italy 108
Correction to: Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 104
Cannabinoids in Autoimmune and Rheumatic Diseases 101
Leptin in autoimmune mechanisms of systemic rheumatic diseases 101
Development and implementation of the AIDA International Registry for patients with Behçet's disease 99
The Relationship Between Metabolic Syndrome and Pain Catastrophizing in Psoriatic Arthritis 95
Polypharmacy is a determinant of hospitalization in Parkinson's disease 95
Pain catastrophizing negatively impacts drug retention rate in patients with Psoriatic Arthritis and axial Spondyloarthritis: results from a 2-years perspective multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica) study 94
A machine-learning approach to cardiovascular risk prediction in psoriatic arthritis 89
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients 88
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still's disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles 85
Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis 83
Association between Patient Acceptable Symptom State and disease activity in psoriatic arthritis is disrupted by confounders, including comorbid fibromyalgia 81
Clinical targeted treatment in Sjogren's disease: A systematic literature review for an evidence-based medicine approach 77
Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 73
The evaluation of type I interferon score in dermatomyositis, a systematic review and a meta-analysis 72
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 72
Multicenter Validation of the DETAIL Questionnaire for the Screening of Spondyloarthritis in Patients With Inflammatory Bowel Diseases 71
Association Between the Use of Oral Contraceptives and the Development of Rheumatoid Arthritis: A Systematic Review and Meta-Analysis 70
Primary versus systemic-sclerosis-associated Raynaud's phenomenon: relationship with clinical and environmental factors 69
The assessment of the drug retention rate of secukinumab in patients with psoriatic arthritis in a real-life multicentre cohort 66
Novel biomarker for pulmonary vascular disease in systemic sclerosis patients 66
Euthymic despite pain: the role of cognitive reappraisal and experiential avoidance in autoimmune inflammatory rheumatic diseases—a cross-sectional study 65
The assessment of atlantoaxial joint involvement in patients with rheumatoid arthritis, results from an observational “real-life” study 65
The Association of Olfactory Dysfunction, Frailty, and Mortality Is Mediated by Inflammation: Results from the InCHIANTI Study 63
Role of the specialized proresolving mediator resolvin D1 in systemic lupus erythematosus: preliminary results 61
Co-Occurrence of Anti-Synthetase Syndrome and Sjögren Disease: A Case-Based Review 60
Patients with psoriatic arthritis and comorbid metabolic syndrome show a difficult-to-treat phenotype: another mosaic tile in the definition of a still undefined subset of patients 59
Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study 59
Diminished expression of the ubiquitin-proteasome system in early treatment-naïve patients with rheumatoid arthritis and concomitant type 2 diabetes may be linked to IL-1 pathway hyper-activity; results from PEAC cohort 59
Long-term Safety of Rituximab in Primary Sjögren Syndrome: The Experience of a Single Center 58
Late-Onset and Elderly Psoriatic Arthritis: Clinical Aspects and Management 57
The relation between, metabolic syndrome and quality of life in patients with Systemic Lupus Erythematosus 57
Pattern of sleep dysfunction in systemic lupus erythematosus: a cluster analysis 57
Phase angle could be a marker of microvascular damage in systemic sclerosis 57
Erythema Multiforme Induced by Secukinumab: Clinical, Dermoscopic, and Histological Features 56
Evaluation of Myocarditis in Patients With Still Disease: Clinical Findings From the Multicenter International AIDA Network Still Disease Registry 55
From pain catastrophising to multidimensional psychological distress: unravelling the complexity of difficult-to-treat psoriatic arthritis 55
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 55
JAK inhibitors in immune-mediated rheumatic diseases: From a molecular perspective to clinical studies 55
Increased Prevalence of Headaches and Migraine in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: Insights from an Italian Cohort Study 55
Efficacy of canakinumab in patients with Still’s disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for Still’s Disease 54
Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 53
The Patrick-FABER test in detecting active sacroiliitis in spondyloarthritis patients: a prospective study using magnetic resonance as reference standard 53
Still’s disease continuum from childhood to elderly: data from the international AIDA Network Still’s disease registry 52
One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study 51
The similar expression of both ferritin and scavenger receptors activation genes in patients with COVID19 and AOSD support their role in the pathogenesis of these diseases and identify a common mechanism at the basis of the "hyperferritinemic syndromes" 51
Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical setting 51
Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study 51
Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart? 51
Female sexual dysfunction in systemic sclerosis: The role of endothelial growth factor and endostatin 50
Polyunsaturated fatty acids: any role in rheumatoid arthritis? 50
Necrobiosis-Lipoidica-Like Skin Lesions in a Patient with Non-Systemic Sarcoidosis 50
Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review 50
Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset "sine psoriasis". 50
LOW-DOSE ASPIRIN MAY HAVE A ROLE AS PRIMARY PROPHYLAXIS OF CARDIOVASCULAR EVENTS IN RHEUMATOID ARTHRITIS: EVIDENCE FROM AN ITALIAN MULTICENTRIC RETROSPECTIVE STUDY 50
The negative impact of pain catastrophising on disease activity: analyses of data derived from patient-reported outcomes in psoriatic arthritis and axial spondyloarthritis 49
The association between duration of remission, fatigue, depression and health-related quality of life in Italian patients with systemic lupus erythematosus 49
Experimental and Investigational Pharmacotherapy for Psoriatic Arthritis: Drugs of the Future 49
Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 49
Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patients 49
Development and Implementation of the AIDA International Registry for Patients With Still's Disease 48
Physical activity and sedentary behavior in patients with Systemic Lupus Erythematosus 48
Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud's phenomenon: a case-control study 47
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis 47
Performance and calibration of the algorithm ASSIGN in predicting cardiovascular disease in Italian patients with psoriatic arthritis 47
Inflammation as a mediator of the association between osteoporosis and hearing loss in older subjects: a population-based study 47
Metabolic syndrome is associated with better quality of sleep in the oldest old: results from the "Mugello Study" 47
Endothelial-to-mesenchymal transition in systemic sclerosis 47
Diagnosis of COVID-19 associated arthritis in patients with or without underlying rheumatic and musculoskeletal disease supported by musculoskeletal ultrasound: a case series from three European centres 46
Totale 9.146
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.181
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.181
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022119 0 1 2 0 0 0 2 4 21 6 2 81
2022/2023165 1 0 5 4 60 0 6 5 6 7 63 8
2023/2024422 16 53 18 50 45 164 8 18 7 12 21 10
2024/20254.807 49 58 141 90 92 131 73 21 321 328 1.545 1.958
2025/20265.027 490 229 479 528 232 279 1.263 311 325 441 315 135
Totale 10.540